Rice Hall James & Associates LLC Invests $10.37 Million in Aspen Aerogels, Inc. $ASPN

Key Points

• Rice Hall James & Associates acquired 1.64 million Aspen Aerogels shares worth approximately $10.37 million, representing about 1.97% of the company. Institutional investors collectively own 97.64% of ASPN.
• Aspen Aerogels reported quarterly revenue of $49.85 million, exceeding estimates of $42.42 million, while its loss of $0.22 per share narrowly beat expectations. The company remains unprofitable, with a negative net margin of 62.45%.
• Analyst sentiment is mixed, resulting in a consensus “Hold” rating and a $5.94 price target. ASPN recently traded at $5.83, with ratings ranging from “Buy” to “Sell.”

Rice Hall James & Associates LLC purchased a new stake in Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 1,635,259 shares of the construction company's stock, valued at approximately $10,368,000. Rice Hall James & Associates LLC owned approximately 1.97% of Aspen Aerogels at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of the stock. Royal Bank of Canada boosted its position in Aspen Aerogels by 84.7% in the first quarter. Royal Bank of Canada now owns 56,419 shares of the construction company's stock valued at $360,000 after buying an additional 25,880 shares in the last quarter. AQR Capital Management LLC acquired a new stake in shares of Aspen Aerogels during the first quarter worth approximately $960,000. Integrated Wealth Concepts LLC bought a new position in shares of Aspen Aerogels in the first quarter valued at approximately $84,000. Goldman Sachs Group Inc. raised its stake in shares of Aspen Aerogels by 89.7% in the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company's stock valued at $8,143,000 after acquiring an additional 602,586 shares during the last quarter. Finally, Caxton Associates LLP acquired a new position in shares of Aspen Aerogels in the 1st quarter worth approximately $307,000. Institutional investors and hedge funds own 97.64% of the company's stock.

Aspen Aerogels Price Performance

Shares of ASPN stock opened at $5.83 on Tuesday. Aspen Aerogels, Inc. has a 1 year low of $2.30 and a 1 year high of $9.35. The company has a current ratio of 2.52, a quick ratio of 2.24 and a debt-to-equity ratio of 0.36. The firm's 50 day moving average is $5.52 and its 200-day moving average is $4.53. The firm has a market capitalization of $483.83 million, a price-to-earnings ratio of -3.81 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The construction company reported ($0.22) earnings per share for the quarter, beating analysts' consensus estimates of ($0.23) by $0.01. Aspen Aerogels had a negative net margin of 62.45% and a negative return on equity of 31.12%. The business had revenue of $49.85 million during the quarter, compared to analyst estimates of $42.42 million. Aspen Aerogels has set its Q3 2026 guidance at -0.110--0.070 EPS. Sell-side analysts forecast that Aspen Aerogels, Inc. will post -0.69 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. B. Riley Financial restated a "buy" rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Barclays lifted their price objective on Aspen Aerogels from $4.00 to $5.00 and gave the company an "underweight" rating in a research report on Tuesday, August 11th. Weiss Ratings reissued a "sell (d-)" rating on shares of Aspen Aerogels in a research note on Wednesday, June 24th. Wall Street Zen cut Aspen Aerogels from a "hold" rating to a "sell" rating in a report on Saturday. Finally, Roth Capital restated a "buy" rating and issued a $7.75 target price on shares of Aspen Aerogels in a research note on Friday, August 7th. Four analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $5.94.

Aspen Aerogels Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company's product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source